ABCSG 26/SOLE Summary
Phase-III-trial evaluating the role of continuous letrozole vs. intermittent letrozole following 4 to 6 years of prior adjuvant endocrine therapy for postmenopausal women with hormone-receptor-positive, node-positive early-stage breast cancer.
|Coordinating investigator:||Marth, Christian; Innsbruck|
(Click to enlarge)
Link for studyteam-members only
Further information about this trial
Access to these informations only with keyword. If required, please ask the responsible project manager.